Related Experiment Videos
Gene- and cell-based therapeutics for type I diabetes mellitus
R Bottino1, P Lemarchand, M Trucco
1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Gene Therapy
|May 7, 2003
Summary
Gene and cell therapies show promise for treating type 1 diabetes mellitus. While some strategies are ready for clinical trials, others require further development for autoimmune disease treatment.
Area of Science:
- Immunology
- Endocrinology
- Biotechnology
Background:
- Type 1 diabetes mellitus is an autoimmune disorder.
- Gene and cell-based therapies offer potential treatment avenues.
Purpose of the Study:
- To assess the current state of gene and cell-based therapies for type 1 diabetes.
- To identify strategies ready for translational studies and those needing further refinement.
Main Methods:
- Review of gene-engineered immune cells for autoantigen hyporesponsiveness.
- Evaluation of islet and beta cell surrogate transplants with immunoregulatory genes.
- Analysis of vector choice, expression systems, and intervention timing (prophylactic vs. therapeutic).
Main Results:
- Gene and cell therapy strategies have demonstrated proof of concept.
- Some approaches are suitable for initiating translational safety trials.
Conclusions:
- Further technical and conceptual refinement is needed for certain therapeutic strategies.
- The field is advancing towards clinical application for type 1 diabetes treatment.